Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name of 'emestedastat' to Actinogen for its Xanamem ® /UE2343 once-a-day small ...

Now, research has found that higher levels of light pollution are associated with a greater prevalence of Alzheimer’s disease, the most common cause of dementia.

The Washington University trial comes as part of a larger platform study, which hopes to understand whether the disease can ...

Delayed REM sleep may be linked to a higher risk of Alzheimer’s disease, new research found. Here's how to build a healthy sleep routine.

The findings suggest that mild or moderate Covid-19 may accelerate biological processes that contribute to the buildup of ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

An international research team has identified key genetic factors that confer protective effects against Alzheimer's disease (AD) through a comprehensive genetic analysis of East Asian populations, ...

Social activity not only delays dementia onset an average of five years; it also carries a $500,000 lifetime savings on healthcare costs per person, according to a new paper from Rush University ...

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...